Follow
katarina sebekova
katarina sebekova
Institute of Molecular Biomedicine, Medical Faculty, Comenius University, Bratislava, Slovakia
Verified email at imbm.sk
Title
Cited by
Cited by
Year
Advanced glycation end products and the progressive course of renal disease
A Heidland, K Sebekova, R Schinzel
American Journal of Kidney Diseases 38 (4), S100-S106, 2001
2872001
Treatment targets in renal fibrosis
P Boor, K Šebeková, T Ostendorf, J Floege
Nephrology Dialysis Transplantation 22 (12), 3391-3407, 2007
1972007
Dietary advanced glycation endproducts (AGEs) and their health effects–PRO
K Šebeková, V Somoza
Molecular nutrition & food research 51 (9), 1079-1084, 2007
1952007
Markedly elevated levels of plasma advanced glycation end products in patients with liver cirrhosis–amelioration by liver transplantation
K Šebeková, V Kupčová, R Schinzel, A Heidland
Journal of hepatology 36 (1), 66-71, 2002
1822002
Regular moderate exercise reduces advanced glycation and ameliorates early diabetic nephropathy in obese Zucker rats
P Boor, P Celec, M Behuliak, P Grančič, A Kebis, M Kukan, N Pronayová, ...
Metabolism 58 (11), 1669-1677, 2009
1692009
Neuromuscular electrostimulation techniques: historical aspects and current possibilities in treatment of pain and muscle waisting
A Heidland, G Fazeli, A Klassen, K Sebekova, H Hennemann, U Bahner, ...
Clin Nephrol 79 (Suppl 1), S12-S23, 2013
1632013
Renal disease in obesity: the need for greater attention
P Rutkowski, A Klassen, K Sebekova, U Bahner, A Heidland
Journal of Renal Nutrition 16 (3), 216-223, 2006
1532006
Genotoxicity of advanced glycation end products in mammalian cells
H Stopper, R Schinzel, K Sebekova, A Heidland
Cancer letters 190 (2), 151-156, 2003
1442003
Plasma levels of advanced glycation end products in healthy, long-term vegetarians and subjects on a western mixed diet
K Šebeková, M Krajčovičová-Kudláčková, R Schinzel, V Faist, J Klvanová, ...
European journal of nutrition 40, 275-281, 2001
1252001
Rooibos tea (Aspalathus linearis) partially prevents oxidative stress in streptozotocin-induced diabetic rats
O Ulicna, O Vancova, P Bozek, J Carsky, K Sebekova, P Boor, M Nakano, ...
Physiological Research 55 (2), 157, 2006
1222006
Plasma advanced glycation end products are decreased in obese children compared with lean controls
K Šebeková, V Somoza, M Jarčušková, A Heidland, L Podracká
International Journal of Pediatric Obesity 4 (2), 112-118, 2009
1132009
Plasma Concentration and Urinary Excretion of Nɛ‐(Carboxymethyl)lysine in Breast Milk– and Formula‐fed Infants
K Šebeková, G Saavedra, C Zumpe, V Somoza, K Klenovicsová, ...
Annals of the New York Academy of Sciences 1126 (1), 177-180, 2008
1082008
Advanced glycation end products and nutrition
M Krajčovičová-Kudláčková, K Šebeková, R Schinzel, J Klvanova
Physiol. Res 51 (3), 313-316, 2002
962002
Processing of protein glycation, oxidation and nitrosation adducts in the liver and the effect of cirrhosis
N Ahmed, PJ Thornalley, R Lüthen, D Häussinger, K Sebekova, ...
Journal of hepatology 41 (6), 913-919, 2004
902004
Association of metabolic syndrome risk factors with selected markers of oxidative status and microinflammation in healthy omnivores and vegetarians
K Šebeková, P Boor, M Valachovičová, P Blažíček, V Parrák, K Babinská, ...
Molecular nutrition & food research 50 (9), 858-868, 2006
892006
Towards an alternative testing strategy for nanomaterials used in nanomedicine: lessons from NanoTEST
M Dusinska, S Boland, M Saunders, L Juillerat-Jeanneret, L Tran, ...
Nanotoxicology 9 (sup1), 118-132, 2015
882015
Accumulation of free adduct glycation, oxidation, and nitration products follows acute loss of renal function
N Rabbani, K Sebekova, K Sebekova Jr, A Heidland, PJ Thornalley
Kidney International 72 (9), 1113-1121, 2007
852007
Effects of ramipril in nondiabetic nephropathy: improved parameters of oxidatives stress and potential modulation of advanced glycation end products
K Šebeková, K Gazdikova, D Syrova, P Blažíček, R Schinzel, A Heidland, ...
Journal of human hypertension 17 (4), 265-270, 2003
792003
Testing strategies for the safety of nanoparticles used in medical applications
M Dusinska, M Dusinska, LM Fjellsb⊘, Z Magdolenova, A Rinna, ...
Nanomedicine 4 (6), 605-607, 2009
692009
Renal effects of S18886 (Terutroban), a TP receptor antagonist, in an experimental model of type 2 diabetes
K Sebekova, T Eifert, A Klassen, A Heidland, K Amann
Diabetes 56 (4), 968-974, 2007
662007
The system can't perform the operation now. Try again later.
Articles 1–20